Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

This study has been completed.

Study NCT00750425 Information provided by AstraZeneca

First Received: September 8, 2008 Last Updated: March 9, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2011
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)